WebSep 9, 2024 · Grail on Wednesday filed with the U.S. Securities and Exchange Commission to raise up to $100 million in an initial public offering ahead of the anticipated launch of … WebSep 9, 2024 · The company, which is developing a blood test to identify early-stage cancers, has set a placeholder amount of $100 million for the IPO, without disclosing the size of …
GRAIL Company Profile: Acquisition & Investors PitchBook
WebSep 9, 2024 · Cancer diagnostic specialist Grail today filed for an initial public offering (IPO) on the Nasdaq, with the stock to trade under the ticker symbol GRAL. The start-up has raised almost $2... WebSep 21, 2024 · Dive Brief: Illumina has agreed to acquire Grail in an $8 billion deal that could establish the sequencing giant as a leading player in the growing race to use blood-based tests known as liquid biopsies to catch cancers early.; Grail spun out of Illumina in 2016 and raised $2 billion to back its work. Long-rumored to be considering an initial … can osteo bi flex raise blood pressure
Grail IPO - Investing Pre-IPO - Forge Global
WebAug 18, 2024 · SAN DIEGO, /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early … WebJun 17, 2024 · Lyell was founded in 2024 by Richard Klausner, former director of the National Cancer Institute and a co-founder of cell therapy company Juno Therapeutics and diagnostics firm Grail. Prior to its... WebSep 11, 2024 · GRAIL is headquartered in Menlo Park, CA with locations in Washington, D.C., North Carolina, and the United Kingdom. GRAIL, LLC, is a subsidiary of Illumina, Inc. (NASDAQ:ILMN) currently held separate from Illumina Inc. under the terms of the Interim Measures Order of the European Commission dated 29 October 2024. flake photography